• Mashup Score: 2
    Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non–Small Cell Lung Cancer - 10 month(s) ago

    AbstractPurpose:. ATM is the most commonly mutated DNA damage and repair gene in non–small cell lung cancer (NSCLC); however, limited characterization has been pursued.Experimental Design:. Clinicopathologic, genomic, and treatment data were collected for 5,172 patients with NSCLC tumors which underwent genomic profiling. ATM IHC was performed on 182 NSCLCs with ATM mutations. Multiplexed…

    Source: American Association for Cancer Research
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      Important work by multicenter team, advancing clinical utility of DDR mutations in #lungcancer ATM mut will be also radiosensitive & perhaps explain the sometimes striking responses we see in patients?! #LCSM #radonc #radbio @OncoAlert @xrtGenomics https://t.co/2mvPjlxnAd

  • Mashup Score: 5
    Radiation Biology & Research Program – MGH Radiation Biology - 1 year(s) ago

    The mission of the Radiation Biology & Research Programis to broadly support radiation biology research and education in the MGH Department of Radiation Oncology as well as the Cancer Center. The Program serves as a platform for research collaborations, idea exchanges, and resource sharing, with the overarching goal of promoting team science across the main disciplines of radiation oncology –…

    Source: radbio.mgh.harvard.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      📢Thrilled to have Aimee McNamara @aimeelou & Will Hwang @DrWilliamHwang join as Associate Directors of our @MGHCancerCenter #RadBio Program 🙏🙏🙏 New initiatives including #radbio journal club coming soon‼️ ➡️https://t.co/vHhuoxSpRm https://t.co/ovHyRbSjxR https://t.co/dcnNR6rPne

  • Mashup Score: 1
    Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer - 1 year(s) ago

    We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8+ cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in expanding Ki-67+CD8+ and Ki-67+CD4+ T-cell fractions in patients treated with 10 Gy or less per fraction….

    Source: www.nature.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      Cool collaborative work by @danduda9 @MGHSteeleLabs @SimonLo21054188 @UniFreiburg & others👍 Systemic immune modulation by SBRT in #lungcancer in @Nature_NPJ ☢️🫁 open access ➡️https://t.co/4Z8hVBUvOx #radonc #radbio #LCSM @OncoAlert https://t.co/862HjfNuOJ https://t.co/tABD7ARLQ5

  • Mashup Score: 1
    ABR - 1 year(s) ago

    Study Guide for Radiation and Cancer Biology Last verified on June 3, 2022 Download this study guide in printable .pdf format This exam tests your knowledge of the principles of radiation and cancer biology underlying the practice of radiation oncology. Included are questions on the general domains listed below. Exam performance will be reported to…

    Source: The American Board of Radiology
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      #radbio always gets me excited 😊 🔬☢️ https://t.co/bzTxU0Just https://t.co/wVkvxXspnw

  • Mashup Score: 3
    NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells - 1 year(s) ago

    Abstract. Radiotherapy is one of the primary treatments of head and neck squamous cell carcinoma (HNSCC), which has a high risk of locoregional failure (LRF). Presently, there is no reliable predictive biomarker of radioresistance in HNSCC. Here, we found that mutations in NFE2L2, which encodes Nrf2, are associated with a significantly higher rate of LRF in patients with oral cavity cancer…

    Source: American Association for Cancer Research
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      Precision radiation medicine coming to #HNCSM🚗😊 📢Mutant NRF confers head & neck cancer radioresistance which can be overcome by @NCICTEP_ClinRes glutaminase inhibitor Cool study @Qle_stanford @max_diehn @StanfordRadOnc #radonc #radbio🙏 @OncoAlert https://t.co/0bMuXUtIgX

  • Mashup Score: 0
    A giant in radiotherapy has gone: Herman D. Suit 1926–2022 - 1 year(s) ago

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…

    Source: www.sciencedirect.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HenningWillers
      HenningWillers

      1/4 💚Wonderful eulogy in @RadiotherapyOn1 by @profOvergaard & @_MichaelBaumann who both were able to work with and learn from Dr. Herman D. Suit 1926–2022 💚 🙏🙏🙏 #radonc #radbio #medphys #MedEd #mentorship @ESTRO_RT @ASTRO_org @RRS_RadRes https://t.co/H8P5BoKR5y

Load More